Insiders · Profile

JUNIUS DANIEL M

Director at Idexx Laboratories · Director at CRESCENT BIOPHARMA. Filing since 3 Aug 2015. CIK 0001094159

Company
Date
Role
Action
Shares
Amount
Of holding
13 May 2025
Director
Sold at will
2,683
$1.36M
44.8%
10 May 2023
Director
Bought
30,000
$46.80K
47.4%
16 Feb 2023
Director
Sold, plan not stated
2,187
$1.12M
42.3%
5 Dec 2022
Director
Sold, plan not stated
3,046
$1.29M
50.6%
17 Nov 2022
Director
Bought
20,000
$37.40K
46.2%
10 Aug 2021
Director
Sold, plan not stated
2,402
$1.63M
45.3%
21 May 2021
Director
Sold, plan not stated
2,500
$1.35M
46.4%
22 Feb 2021
Director
Sold, plan not stated
1,898
$1.02M
39.8%
20 Aug 2020
Director
Sold, plan not stated
3,722
$1.42M
56.7%
19 May 2020
Director
Bought
4,000
$1.18M
opened
9 Mar 2020
Director
Bought
20,000
$68.00K
111%
13 Aug 2019
Director
Bought
10,000
$31.80K
125%
28 Feb 2018
Director
Sold, plan not stated
2,974
$565.23K
53.1%
8 Feb 2017
Director
Sold, plan not stated
3,000
$425.26K
54.6%
20 Dec 2016
Director
Bought
5,000
$30.05K
opened
3 Aug 2015
Director
Bought
1,000
$73.15K
87.0%
16 decisions on file.